Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-10-012368
Filing Date
2010-02-12
Accepted
2010-02-12 17:00:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G g22082sc13g.htm SC 13G 29349
  Complete submission text file 0000950123-10-012368.txt   30959
Mailing Address 1207 17TH AVENUE SUITE 103 NASHVILLE TN 37212
Business Address
KAZIMI A J (Filed by) CIK: 0001075050 (see all company filings)

Type: SC 13G

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-85205 | Film No.: 10600629
SIC: 2834 Pharmaceutical Preparations